Patent details

EP1948149 Title: FORMULATION COMPRISING METFORMIN AND VILDAGLIPTIN

Basic Information

Publication number:
EP1948149
PCT Application Number:
US2006037198
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP068153055
PCT Publication Number:
WO2007041053
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FORMULATION COMPRISING METFORMIN AND VILDAGLIPTIN
French Title of Invention:
NOUVELLE FORMULATION CONTENANT METFORMIN ET VILDAGLIPTIN
German Title of Invention:
FORMULIERUNG MIT METFORMIN UND VILDAGLIPTIN
SPC Number:

Dates

Filing date:
25/09/2006
Grant date:
16/11/2011
EP Publication Date:
30/07/2008
PCT Publication Date:
12/04/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/07/2008
EP B1 Publication Date:
16/11/2011
EP B2 Publication Date:
06/07/2022
EP B3 Publication Date:
Lapsed date:
25/09/2023
Expiration date:
25/09/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/06/2022
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
11/07/2022
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
KOWALSKI, James
Address:
United States (US)

2

Name:
ROYCE, Alan, Edward
Address:
United States (US)

3

Name:
JOSHI, Yatindra
Address:
United States (US)

4

Name:
LAKSHMAN, Jay, Parthiban
Address:
United States (US)

5

Name:
VASANTHAVADA, Madhav
Address:
United States (US)

6

Name:
TONG, Wei-Qin
Address:
United States (US)

Priority

Priority Number:
722624 P
Priority Date:
29/09/2005
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/155; A61K 31/40; A61P 3/10; A61K 9/20; A61K 9/48; A61K 31/4439;

Publication

European Patent Bulletin

1

Issue number:
202131
Publication date:
04/08/2021
Description:
Decision on Petition for review

2

Issue number:
202227
Publication date:
06/07/2022
Description:
Patent maintained (B2 publication)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
16/09/2022
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
246 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
11/07/2022 Power Of Attorney 1
11/07/2022 Outgoing Correspondence 1